Hepatitis C virus infection in haemodialysis patients: "Wolf in sheep's clothing"

Medical Journal Armed Forces India

Volumn 61, Issue 3, 2005, Pages 241-244

  Chopra, G S ^a   Gupta, R M ^b   Gedela, S R ^c   Varma, P P ^a   Rai, R ^d   Nema, S K ^b  

^a ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^b ARMED FORCES MEDICAL COLLEGE   (India)

^c MILITARY HOSPITAL   (India)

^d Medical Services (Army)   (India)

Author keywords

Haemodialysis; Hepatitis C virus

Indexed keywords

ANTIBODY; RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 28044464525     PISSN: 03771237     EISSN: 03771237     Source Type: Journal    
DOI: 10.1016/S0377-1237(05)80163-7     Document Type: Article

References (17)

1. World Health Organization : Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 2000;75:17-28.
2. Zeldis JB, Depner TA, Kuramoto IK et al. The prevalence of HCV antibodies among haemodialysis patients. Ann Intern Med 1990;112:958-60.
3. Chan TM, Lok ASF and Cheng IKP. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl 1991;6:944-7.
4. Niu MT, Coleman PJ, Alter MJ. Multicenter study of Hepatitis C infection in chronic haemodialysis patients and haemodialysis center staff members. Am J Kidney Dis 1993;22:568-73.
5. Sampeitro M, Badalamenti S, Salvadori S, et al. High prevalence of a rare hepatitis C virus in patients treated in the same haemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int 1995;47:911-17.
6. Tanaka E, Kiyosawa K, Matsumoto A, et al. Serum levels of HCV core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology 1996;23:1330-33.
7. Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs and drug users. Lancet 1990;339:1469-72.
8. Kato N, Yokosuka O, Omata M, et al. Detection of HCV RNA in the serum by amplification with PCR. J Clin Invest 1990; 86:1764-64.
9. Farei P, Alter HJ, Wong D, et al. A long-term study of hepatitis C virus replication in non-A non-B Hepatitis. N Engl J Med 1991;325:98-104.
10. Zeldis JB, Depner TA, Kuramoto IK et al. The prevalence of HCV antibodies among haemodialysis patients. Ann Intern Med 1990;112:958-60.
11. Chadha MS, Arankalle VA, Jha J and Banerjee K. Prevalence of hepatitis B and C virus infections among haemodialyis patients in Pune (western India). Vox Sang 1993;64:127-38.
12. Arankalle VA, Chasa MS, Jha J, et al. Prevalence of anti-HCV antibodies in western India. Ind J Med Res 1995;101:91-3.
13. Dittman S, Roggendorf M, Durkop J, et al. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatology 1991;13:323-7.
14. Curthbertson B, Reid KJ, Foster PR. Viral contamination of human plasma and procedures for preventing virus transmission by plasma products. Pp.385-435. In Harris JR (ed): Blood Separation and Plasma Fractionation. Wiley-Liss, New York, 1991.
15. Goldblum SE, Reed WP. Host defenses and Immunologic alterations associated with chronic haemodialysis. Ann Intern Med 1980;93:597-613.
16. Simon N, Courouce AM, Lemarrec N, et al. A twelve-year natural history of hepatitis C virus infection in haemodialized patients. Kidney International 1994;46:504-11.
17. Chan TM, Lok ASF, Cheng IKP and Chan RT. Prevalence of HCV infection in dialysis patients: A longitudinal study comparing the results of RNA and Antibody tests. Hepatology 1993;17:5-8.